Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Rapid Micro Biosystems Community
NasdaqCM:RPID Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Community Investing Ideas
Rapid Micro Biosystems
Popular
Undervalued
Overvalued
Rapid Micro Biosystems
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Global Automation And Regulatory Emphasis Will Drive Pharmaceutical Modernization
Key Takeaways Rising demand for automated, data-driven microbiology QC and regulatory shifts supports strong system placements and recurring consumables revenue, strengthening growth and margins. Strategic partnerships and operational efficiencies drive expanded commercial reach, cost leverage, and improve financial stability through recurring revenues and margin expansion.
View narrative
US$8.00
FV
69.3% undervalued
intrinsic discount
16.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
RPID
RPID
Rapid Micro Biosystems
Your Fair Value
US$
Current Price
US$2.46
46.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-68m
68m
2015
2018
2021
2024
2025
2027
2030
Revenue US$67.5m
Earnings US$8.6m
Advanced
Set Fair Value